Approval · Notice of Compliance 30328 · 2023
MICRO+ TE PEDIATRIC: Notice of Compliance 30328
Issued March 15, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30328
- Date
- March 15, 2023
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO+ TE PEDIATRIC | 02536145 | Marketed |
Medicinal ingredients
- CUPRIC SULFATE 20 MCG per ML
- MANGANESE SULFATE 1 MCG per ML
- SELENIOUS ACID 2 MCG per ML
- SODIUM IODIDE 1 MCG per ML
- ZINC SULFATE 250 MCG per ML